ContraFect Corporation (CFRXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -64.99 Million USD | -20.41% |
| 2021 | -20.13 Million USD | -38.29% |
| 2020 | -27.98 Million USD | -23.01% |
| 2019 | -12.62 Million USD | 13.97% |
| 2018 | -37.53 Million USD | -22.06% |
| 2017 | -15.33 Million USD | 20.27% |
| 2016 | -28.08 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -7.93 Million USD | 10.02% |
| 2023 Q3 | -6.63 Million USD | 16.33% |
| 2023 Q1 | -8.81 Million USD | -32.32% |
| 2022 Q1 | -15.94 Million USD | -13.52% |
| 2022 Q3 | -14.14 Million USD | 29.25% |
| 2022 Q4 | -6.66 Million USD | 52.87% |
| 2022 Q2 | -19.98 Million USD | -25.39% |
| 2022 FY | - USD | -20.41% |
| 2021 Q3 | -11.64 Million USD | 0.0% |
| 2021 FY | - USD | -38.29% |
| 2021 Q4 | -14.04 Million USD | -20.55% |
| 2020 FY | - USD | -23.01% |
| 2019 FY | - USD | 13.97% |
| 2018 FY | - USD | -22.06% |
| 2017 FY | - USD | 20.27% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 8.499% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -996.306% |
| SQZ Biotechnologies Company | -64.14 Million USD | -1.338% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -274.203% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 169.12% |
| Mesoblast Limited | -62.38 Million USD | -4.182% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -4131.571% |
| Genus plc | 73.7 Million USD | 188.194% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -883.118% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -1732.507% |
| Marizyme, Inc. | -34.28 Million USD | -89.604% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -640.983% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -1336.063% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -4536.798% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -2357.942% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -2697.076% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -12446.955% |
| Accustem Sciences Inc. | -3.74 Million USD | -1634.963% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -34.777% |
| EV Biologics, Inc. | -1.26 Million USD | -5029.616% |
| Q BioMed Inc. | -617.62 Thousand USD | -10423.972% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 1919.681% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -10178.049% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -2745.231% |
| Biomind Labs Inc. | -1.03 Million USD | -6182.834% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 758.084% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -807.646% |
| Skye Bioscience, Inc. | -13.54 Million USD | -379.784% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -4269.939% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -259896.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -1573.369% |
| IMV Inc. | -35.52 Million USD | -82.975% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -309.578% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -2497.921% |
| GB Sciences, Inc. | -1.41 Million USD | -4477.765% |
| Alpha Cognition Inc. | -9.7 Million USD | -569.706% |
| HST Global, Inc. | -5303.00 USD | -1225602.433% |
| CSL Limited | 4.78 Billion USD | 101.357% |
| Halberd Corporation | -74.27 Thousand USD | -87406.563% |
| Enzolytics Inc. | -2.12 Million USD | -2963.059% |
| Resverlogix Corp. | -11.74 Million USD | -453.56% |
| Affymax, Inc. | -14.29 Million USD | -354.697% |
| SYBLEU INC | -141.57 Thousand USD | -45812.652% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -2022.059% |
| argenx SE | -216.02 Million USD | 69.911% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -17.456% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 5440.92% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -4236.429% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 17257.194% |
| AVAX Technologies, Inc. | -6.11 Million USD | -963.353% |
| Zenith Capital Corp. | -8.6 Million USD | -655.275% |
| Genscript Biotech Corporation | -248.71 Million USD | 73.867% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -373007.17% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -2556.858% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -36826.139% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -63.986% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -2147.292% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -6112.201% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 966771.624% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -3614.231% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -3283.759% |
| BioStem Technologies, Inc. | -7.55 Million USD | -760.498% |
| ONE Bio Corp. | 13.61 Million USD | 577.476% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -35793.599% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -3059.893% |
| Agentix Corp. | -1.37 Million USD | -4638.379% |
| LadRx Corporation | 412.28 Thousand USD | 15865.627% |
| Cell Source, Inc. | -4.27 Million USD | -1421.325% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -17600.24% |
| Regen BioPharma, Inc. | 1.46 Million USD | 4533.898% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -6837.304% |
| NovAccess Global Inc. | -1.03 Million USD | -6181.329% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 834.137% |
| Itoco Inc. | -1.86 Million USD | -3377.751% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -17022.122% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -5724.283% |
| Kadimastem Ltd | -2.62 Million USD | -2376.736% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -27079.176% |
| CytoDyn Inc. | -18.02 Million USD | -260.525% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -82147.023% |
| Mobile Lads Corp. | -2.24 Million USD | -2800.24% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -531415.251% |
| Qrons Inc. | -40.08 Thousand USD | -162069.108% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -13283.147% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 12423.651% |
| Rebus Holdings, Inc. | -951 Thousand USD | -6734.805% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -6020.376% |
| International Stem Cell Corporation | 202 Thousand USD | 32277.723% |
| Bioxytran, Inc. | -3.82 Million USD | -1601.479% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -123378.343% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -2540.162% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -81.212% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -144342.222% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -2273.959% |
| Neutra Corp. | -181.24 Thousand USD | -35762.111% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -222.432% |
| PureTech Health plc | -11.62 Million USD | -459.035% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -222.454% |
| IXICO plc | -707 Thousand USD | -9093.635% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -745.791% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -34.445% |
| CSL Limited | 4.73 Billion USD | 101.373% |
| Cellectis S.A. | -92.63 Million USD | 29.834% |